BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31550657)

  • 41. Fasciola hepatica leucine aminopeptidase, a promising candidate for vaccination against ruminant fasciolosis.
    Acosta D; Cancela M; Piacenza L; Roche L; Carmona C; Tort JF
    Mol Biochem Parasitol; 2008 Mar; 158(1):52-64. PubMed ID: 18178266
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Th1/Th2 balance in the liver and hepatic lymph nodes of vaccinated and unvaccinated sheep during acute stages of infection with Fasciola hepatica.
    Pacheco IL; Abril N; Morales-Prieto N; Bautista MJ; Zafra R; Escamilla A; Ruiz MT; Martínez-Moreno A; Pérez J
    Vet Parasitol; 2017 Apr; 238():61-65. PubMed ID: 28385539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peritoneal lavage cells of Indonesian thin-tail sheep mediate antibody-dependent superoxide radical cytotoxicity in vitro against newly excysted juvenile Fasciola gigantica but not juvenile Fasciola hepatica.
    Piedrafita D; Estuningsih E; Pleasance J; Prowse R; Raadsma HW; Meeusen EN; Spithill TW
    Infect Immun; 2007 Apr; 75(4):1954-63. PubMed ID: 17210661
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The addition of a new immunomodulator with the adjuvant adaptation ADAD system using fatty acid binding proteins increases the protection against Fasciola hepatica.
    López-Abán J; Nogal-Ruiz JJ; Vicente B; Morrondo P; Diez-Baños P; Hillyer GV; Martínez-Fernández AR; Feliciano AS; Muro A
    Vet Parasitol; 2008 May; 153(1-2):176-81. PubMed ID: 18308471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blood leukocyte responses in rats vaccinated with cDNA encoding glutathioinie-S-transferase of Fasciola hepatica.
    Wedrychowicz I; Jedlina-Panasiuk L; Szymanski P; Bieńkowska-Szewczyk K
    Wiad Parazytol; 2001; 47(4):551-7. PubMed ID: 16886389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica.
    Rivera F; Espino AM
    Exp Parasitol; 2016 Jan; 160():31-8. PubMed ID: 26632503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stimulation of resistance to Fasciola hepatica infection in sheep by a regime involving the use of the immunomodulatory compound L tetramisole (levamisole).
    Mitchell GB; Armour J
    Res Vet Sci; 1981 May; 30(3):343-8. PubMed ID: 7255928
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intranasal delivery of a formulation containing stage-specific recombinant proteins of Fasciola hepatica cathepsin L5 and cathepsin B2 triggers an anti-fecundity effect and an adjuvant-mediated reduction in fluke burden in sheep.
    Norbury LJ; Basałaj K; Zawistowska-Deniziak A; Sielicka A; Wilkowski P; Wesołowska A; Smooker PM; Wędrychowicz H
    Vet Parasitol; 2018 Jul; 258():14-23. PubMed ID: 30105973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protection against Fasciola hepatica in rats with adult fluke antigen in Freund's adjuvant: influence of antigen batch, antigen dose and number of sensitising injections.
    Oldham G
    Res Vet Sci; 1983 Mar; 34(2):240-4. PubMed ID: 6856998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fasciola hepatica and Fasciola gigantica: comparison of cellular response to experimental infection in sheep.
    Zhang WY; Moreau E; Hope JC; Howard CJ; Huang WY; Chauvin A
    Exp Parasitol; 2005 Nov; 111(3):154-9. PubMed ID: 16126202
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fasciola gigantica enolase is a major component of worm tegumental fraction protective against sheep fasciolosis.
    Mahana N; Abd-Allah HA; Salah M; Tallima H; El Ridi R
    Acta Trop; 2016 Jun; 158():189-196. PubMed ID: 26970372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early immunodiagnosis of fasciolosis in ruminants using recombinant Fasciola hepatica cathepsin L-like protease.
    Cornelissen JB; Gaasenbeek CP; Borgsteede FH; Holland WG; Harmsen MM; Boersma WJ
    Int J Parasitol; 2001 May; 31(7):728-37. PubMed ID: 11336755
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Naltrexone; as an efficient adjuvant in induction of Th1 immunity and protection against Fasciola hepatica infection.
    Azizi H; Mirzaeei H; Nasiri AA; Bazi A; Mirzapour A; Khatami M; Nahavandi KH; Azimi A; Yaghoobi H
    Exp Parasitol; 2018 Jun; 189():66-71. PubMed ID: 29729492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Progress in the development of Fasciola hepatica vaccine using recombinant fatty acid binding protein with the adjuvant adaptation system ADAD.
    López-Abán J; Casanueva P; Nogal J; Arias M; Morrondo P; Diez-Baños P; Hillyer GV; Martínez-Fernández AR; Muro A
    Vet Parasitol; 2007 Apr; 145(3-4):287-96. PubMed ID: 17275191
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the immune response of male and female rats vaccinated with cDNA encoding a cysteine proteinase of Fasciola hepatica (FhPcW1).
    Wesołowska A; Norbury LJ; Januszkiewicz K; Jedlina L; Jaros S; Zawistowska-Deniziak A; Zygner W; Wędrychowicz H
    Acta Parasitol; 2013 Jun; 58(2):198-206. PubMed ID: 23666656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A mucin-like peptide from Fasciola hepatica induces parasite-specific Th1-type cell immunity.
    Noya V; Brossard N; Berasaín P; Rodríguez E; Chiale C; Mazal D; Carmona C; Freire T
    Parasitol Res; 2016 Mar; 115(3):1053-63. PubMed ID: 26637311
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines.
    Dalton JP; Neill SO; Stack C; Collins P; Walshe A; Sekiya M; Doyle S; Mulcahy G; Hoyle D; Khaznadji E; Moiré N; Brennan G; Mousley A; Kreshchenko N; Maule AG; Donnelly SM
    Int J Parasitol; 2003 Sep; 33(11):1173-81. PubMed ID: 13678633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolation, identification and expression of a Fasciola hepatica cDNA encoding a 2.9-kDa recombinant protein for the diagnosis of ovine fasciolosis.
    Paz-Silva A; Hillyer GV; Sánchez-Andrade R; Rodríguez-Medina JR; Arias M; Morrondo P; Díez-Baños P
    Parasitol Res; 2005 Jan; 95(2):129-35. PubMed ID: 15609063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunization with Fasciola hepatica thioredoxin glutathione reductase failed to confer protection against fasciolosis in cattle.
    Maggioli G; Bottini G; Basika T; Alonzo P; Salinas G; Carmona C
    Vet Parasitol; 2016 Jul; 224():13-19. PubMed ID: 27270384
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lack of humoral and cellular responses against glutathione S-transferases in Fasciola hepatica experimentally infected sheep.
    Moreau E; Chauvin A; Boulard C
    Vet Res; 1998; 29(6):585-91. PubMed ID: 9851016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.